Domain Therapeutics and Ono Sign Collaboration Agreement

News   Oct 23, 2012

 
Domain Therapeutics and Ono Sign Collaboration Agreement
 
 
 
 

RELATED ARTICLES

CRISPR Reveals New Targets for Promising Cancer Drugs

News

Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.

READ MORE

BioAscent Announces New CEO and Plans to Expand Discovery Services Offering

News

BioAscent Discovery Limited appoints new CEO, Paul Smith in preparation for the expansion of companies discovery services.

READ MORE

Cell Recycling System Offers Therapeutic Entry Point for Rare Disease Treatment

News

Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE